Women around the world who have taken medication to treat attention deficit hyperactivity disorder (ADHD) during their pregnancy can now breathe a sigh of relief. There are no differences in rates of neurodevelopmental disorders between children who were exposed and those who were unexposed to stimulant medication in-utero, according to new research conducted by research conducted by the Icahn School of Medicine at Mount Sinai in New York and Aarhus University in Denmark and published February 9 in Molecular Psychiatry.
https://www.lifetechnology.com/blogs/life-technology-medical-news/study-pregnant-women-on-adhd-medications-shouldnt-worry-about-pediatric-neurodevelopmental-disorders
Buy SuperforceX™
